Vifor Pharma broadcasts adjustments to its Government Committee

Article content material

ST. GALLEN, Switzerland — Regulatory Information:

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR

Vifor Pharma Group as we speak introduced adjustments to its Government Committee as present members Lee Heeson, President Worldwide, and Gregory Oakes, President North America, have determined to go away the corporate for private causes. Succession planning is at the moment underway and will likely be introduced as soon as the method has been concluded.

Article content material

In parallel to those administration adjustments, Vifor Pharma is happy that Molly Painter is becoming a member of the corporate as President U.S., efficient as of 18 October 2021. Molly has a confirmed monitor file of constructing and main organizations throughout a number of therapeutic areas, and intensive expertise in launching and commercializing merchandise within the U.S..

Abbas Hussain, Chief Government Officer of Vifor Pharma Group, commented: “I’m delighted to welcome Molly Painter to Vifor Pharma. She brings a wealth of expertise with over 20 years within the healthcare trade. I need to thank Lee and Greg for his or her contributions to Vifor Pharma and to the Government Committee, particularly for his or her dedication and management of the group through the COVID-19 pandemic. I want them the easiest for his or her future endeavours, each professionally and personally.”

About Vifor Pharma Group
Vifor Pharma Group is a world prescription drugs firm. It goals to turn out to be the worldwide chief in iron deficiency, nephrology and cardio-renal therapies. The corporate is a companion of selection for prescription drugs and progressive patient-focused options. Vifor Pharma Group strives to assist sufferers around the globe with extreme and power ailments lead higher, more healthy lives. The corporate develops, manufactures and markets pharmaceutical merchandise for precision affected person care. Vifor Pharma Group holds a number one place in all its core enterprise actions and consists of the next firms: Vifor Pharma and Vifor Fresenius Medical Care Renal Pharma (a joint firm with Fresenius Medical Care). Vifor Pharma Group is headquartered in Switzerland, and listed on the Swiss Inventory Change (SIX Swiss Change, VIFN, ISIN: CH0364749348).

For extra data, please go to viforpharma.com.

View supply model on businesswire.com: https://www.businesswire.com/news/home/20211011005579/en/

Contacts

Contact and additional data:

Media Relations
Nathalie Ponnier
International Head Company Communications
+41 79 957 96 73
media@viforpharma.com

Investor Relations
Julien Vignot
Head of Investor Relations
+41 58 851 66 90
investors@viforpharma.com

#distro